The dizzying array of new treatments for multiple myeloma is set to become even more complex in the near future, and a new platform trial aims to get a better handle on how the variety of drugs with different modalities and targets can fit into treatment.
With Plethora Of New Myeloma Treatments, MMRF Study Aims To Better Guide Use
The MMRF aims to incorporate a variety of new bispecific antibodies, cell therapies, checkpoint inhibitors and novel small molecules into the Horizon study.
